Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by Stocknovice101on Apr 17, 2018 12:21am
116 Views
Post# 27895303

ISOL NEVER ANNOUNCED THE CLOSING OF CN PHARMA DEAL SO...?

ISOL NEVER ANNOUNCED THE CLOSING OF CN PHARMA DEAL SO...?I wonder if CN pharma recieved their Dealer LIcense , closing the deal with isodiol  and some other deal as a consequence of this  

CN PHARMA WAS AWIAITNG A DEALER LICENSE from health canada at the time of the  signing of the acquisition. the closing of the deal was never announced (unless i am wrong) !

As a certified Licensed Dealer,Once approved by Health Canada, CN Pharma will be licensed to process and manufacture controlled substances, handle all cannabis and hemp derivatives, import and export oils and isolates, prepare various formulation and mixtures, participate in research or testing activities, and conduct new product and drug development.

“The CN Pharma structure will provide Isodiol with a unique opportunity to import optimal cannabis and hemp ingredients from various global centers in to Canada and then process and manufacture to the highest quality pharmaceutical standards. The license will also position Isodiol to export its pharmaceutical products globally from Canada”, said Marcus Dahl, President of CN Pharma.


https://ca.finance.yahoo.com/news/isodiol-international-inc-signs-definitive-130000369.html

regardless of what it it, gl everyone,, i just felt like taking a shot at this :)


Bullboard Posts